eoadjuvant chemotherapy with docetaxel and anthracycline based chemotherapy in patients with advanced breast cancer: Evaluation of biological, clinical and imaging markers of tumour response.

Phase 3

Completed

• Conditions: Breast Cancer; Cancer - Breast

• Registration Number: ACTRN12605000588695
• Lead Sponsor: Monash Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-10-04
• Study Completion: 2017-12-29
• Last Update Posted: 14 June 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 180

Inclusion Criteria

locally advanced breast cancer

Exclusion Criteria

metastatic disease (Stage 4)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Identification of markers that correlate with tumour response to chemotherapy[Measured after surgical removal of tumour]

Secondary Outcome Measures

Name	Time	Method
Disease free and overall survival.[as event occurs]